MarketScreener Editorial Features DiaMedica Inc. Toronto S.E.
Equities
DMA
CA25253T1075
End-of-day quote
Other stock markets
|
||
- CAD | - |
05-09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
04-17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
- Stock Market
- Equities
- DMAC Stock
- DMA Stock
- News DiaMedica Inc.
- MarketScreener Editorial Features